Physician profile
Benjamin Rafii
NPI 1770711277
$5,425.61
in general payments reported to CMS, 2019-2025
31 companies · $805 in 2025
The $805 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,606 · 2020: $176 · 2021: $346 · 2022: $822 · 2023: $839 · 2024: $830 · 2025: $805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,375 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,375.42 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $956.42 | 2019-2025 | Xpress Loprofile, Latera, Scopis Ent |
| Smith+Nephew, INC. | $733.98 | 2019-2023 | Coblation, Ent Sinus, Halo |
| Glaxosmithkline, LLC. | $729.69 | 2021-2025 | Nucala |
| Genzyme Corporation | $664.12 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $623.86 | 2019-2025 | Dupixent |
| Aerin Medical INC. | $292.52 | 2019-2025 | |
| Optinose US, INC. | $270.67 | 2019-2025 | |
| Hologic Sales and Service, LLC | $155.35 | 2023 | Coolseal Generator |
| Merz Pharmaceuticals, LLC | $149.91 | 2022 | |
| Acclarent, INC | $132.15 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $113.49 | 2021-2024 | |
| Baxter Healthcare | $66.33 | 2022-2025 | Perclot |
| Ethicon US, LLC | $62.50 | 2019-2025 | Surgicel Nu-Knit, Harmonic |
| Merck Sharp & Dohme LLC | $45.44 | 2021-2023 | |
| Merz North America, INC. | $42.45 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $42.34 | 2022-2023 | Nuvent |
| Xoran Technologies LLC | $42.06 | 2022 | |
| Hikma Pharmaceuticals USA | $36.93 | 2024 | Ryaltris |
| Agiliti Surgical, INC. | $33.95 | 2019 | |
| Inspire Medical Systems, INC. | $32.50 | 2025 | Inspire |
| Ars Pharmaceuticals Operations, INC. | $28.85 | 2025 | Neffy |
| Precigen, INC. | $26.17 | 2025 | |
| Medline Industries Lp | $21.92 | 2025 | |
| Acera Surgical, INC. | $21.12 | 2021 | |
| Cook Medical LLC | $17.85 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.77 | 2019 | |
| Karl Storz Endoscopy-America | $15.31 | 2019 | |
| Tactile Systems Technology INC | $14.17 | 2020 | |
| Cochlear Americas | $13.09 | 2019 | |
| Intersect Ent, INC. | $12.95 | 2019 | |
| Olympus America INC. | $11.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Rafii listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.